Cargando…
Bilirubin Increases Insulin Sensitivity by Regulating Cholesterol Metabolism, Adipokines and PPARγ Levels
Obesity can cause insulin resistance and type 2 diabetes. Moderate elevations in bilirubin levels have anti-diabetic effects. This study is aimed at determining the mechanisms by which bilirubin treatment reduces obesity and insulin resistance in a diet-induced obesity (DIO) mouse model. DIO mice we...
Autores principales: | Liu, Jinfeng, Dong, Huansheng, Zhang, Yong, Cao, Mingjun, Song, Lili, Pan, Qingjie, Bulmer, Andrew, Adams, David B., Dong, Xiao, Wang, Hongjun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4446899/ https://www.ncbi.nlm.nih.gov/pubmed/26017184 http://dx.doi.org/10.1038/srep09886 |
Ejemplares similares
-
Corrigendum: Bilirubin Increases Insulin Sensitivity by Regulating Cholesterol Metabolism, Adipokines and PPARγ Levels
por: Liu, Jinfeng, et al.
Publicado: (2016) -
Adipose-derived mesenchymal stem cells improve glucose homeostasis in high-fat diet-induced obese mice
por: Cao, Mingjun, et al.
Publicado: (2015) -
Selective Tissue Distribution Mediates Tissue-Dependent PPARγ Activation and Insulin Sensitization by INT131, a Selective PPARγ Modulator
por: Xie, Xinni, et al.
Publicado: (2017) -
Cross-Talk between PPARγ and Insulin Signaling and Modulation of Insulin Sensitivity
por: Leonardini, Anna, et al.
Publicado: (2009) -
Neobavaisoflavone Induces Bilirubin Metabolizing Enzyme UGT1A1 via PPARα and PPARγ
por: Zhu, Ya-Di, et al.
Publicado: (2021)